Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ardent Health, Inc. (ARDT : NYSE)

• Company Description    Ardent Health Partners Inc. is a provider of healthcare. Ardent Health Partners Inc., formerly known as ARDENT HEALTH, is based in BRENTWOOD, Tenn. Number of Employees: 24,900

• Price / Volume Information    Yesterday's Closing Price: $8.83 Daily Weekly Monthly 20 Day Moving Average: 503,470 shares Shares Outstanding: 143.19 (millions) Market Capitalization: $1,264.35 (millions) Beta: 0.72 52 Week High: $17.14 52 Week Low: $8.28 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.45% -0.28% 12 Week -38.42% -39.42% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 340 SEVEN SPRINGS WAY SUITE 100 - BRENTWOOD,TN 37027 USA ph: 615-296-3000 fax: - investor.relations@ardenthealth.com http://www.ardenthealth.com

• General Corporate Information    Officers Martin J. Bonick - President and Chief Executive Officer; Director Alfred Lumsdaine - Chief Financial Officer David Byers - Senior Vice President; Chief Accounting Officer Mark Sotir - Director Peter Bulgarelli - Director Peer Information Ardent Health, Inc. (CHCR) Ardent Health, Inc. (ESRX) Ardent Health, Inc. (MYDP) Ardent Health, Inc. (COR) Ardent Health, Inc. (GBCS) Ardent Health, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 03980N107 SIC: 8062 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/25/26 Share - Related Items Shares Outstanding: 143.19 Most Recent Split Date: (:1) Beta: 0.72 Market Capitalization: $1,264.35 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.28 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $1.45 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 1.24% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/25/26

• Fundamental Ratios P/E Current FY Estimate: 6.10 Trailing 12 Months: 4.13 PEG Ratio: 4.92 Price Ratios Price/Book: 0.77 Price/Cash Flow: 3.48 Price / Sales: 0.20 EPS Growth vs. Year Ago Period: 173.68% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 8.75% vs. Previous Quarter: -4.17% ROE 12/31/25 - - 09/30/25 - 19.02 06/30/25 - 16.66 ROA 12/31/25 - - 09/30/25 - 6.04 06/30/25 - 5.18 Current Ratio 12/31/25 - - 09/30/25 - 2.08 06/30/25 - 2.13 Quick Ratio 12/31/25 - - 09/30/25 - 1.95 06/30/25 - 2.00 Operating Margin 12/31/25 - - 09/30/25 - 4.79 06/30/25 - 4.11 Net Margin 12/31/25 - - 09/30/25 - 3.24 06/30/25 - 4.11 Pre-Tax Margin 12/31/25 - - 09/30/25 - 5.71 06/30/25 - 6.78 Book Value 12/31/25 - - 09/30/25 - 11.41 06/30/25 - 11.52 Inventory Turnover 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.67 06/30/25 - 0.66 Debt-to-Capital 12/31/25 - - 09/30/25 - 39.93 06/30/25 - 39.78

Powered by Zacks Investment Research ©